Federal Register / Vol. 65, No. 186 / Monday, September 25, 2000 / Notices 57611

Dated: September 19, 2000.

Nancy Cheal,

Acting Associate Director for Policy Planning,

and Evaluation, Centers for Disease Control

and Prevention (CDC).

[FR Doc. 00–24531 Filed 9–22–00; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

[30DAY–72–00]

Agency Forms Undergoing Paperwork

Reduction Act Review

The Centers for Disease Control and

Prevention (CDC) publishes a list of

information collection requests under

review by the Office of Management and

Budget (OMB) in compliance with the

Paperwork Reduction Act (44 U.S.C.

Chapter 35). To request a copy of these

requests, call the CDC Reports Clearance

Officer at (404) 639–7090. Send written

comments to CDC, Desk Officer; Human

Resources and Housing Branch, New

Executive Office Building, Room 10235;

Washington, DC 20503. Written

comments should be received within 30

days of this notice.

Proposed Project

Exposure to Aerosolized Brevetoxins

During Red Tide Events—New—

National Center for Environmental

Health (NCEH). Gymnodinium breve is

the marine dinoflagellate responsible for

extensive blooms (called red tides) that

form in the Gulf of Mexico. G. breve

produces potent toxins, called

brevetoxins, that have been responsible

for killing millions of fish and other

marine organisms. The biochemical

activity of brevetoxins is not completely

understood and there is very little

information regarding human health

effects from environmental exposures,

such as inhaling brevetoxin that has

been aerosolized and swept onto the

coast by offshore winds. The National

Center for Environmental Health

(NCEH), Centers for Disease Control and

Prevention (CDC) is planning to recruit

100 people who work along the coast of

Florida and who potentially will be

occupationally exposed to aerosolized

red tide toxins some time during the

year following recruitment.

NCEH plans on administering a base

line respiratory health questionnaire

and conducting pre- and post-shift

pulmonary function tests during a time

when there is no red tide reported near

the area. When a red tide develops, we

plan to administer a symptom survey

and conduct pulmonary function testing

(PFT) on a group of study participants

who are working in the area where the

red tide is near shore, and on a control

group of study participants who are not

working in an area where the red tide

is near shore (i.e., are not exposed to the

red tide). We will then compare (1)

symptom reports before and during the

red tide and (2) the changes in baseline

PFT values during the work shift

(differences between pre- and post-shift

PFT results without exposure to red

tide) with the changes in PFT values

during the work shift when individuals

are exposed to red tide. In addition, we

plan to assist in collecting biological

specimens (inflammatory cells from

nose and throat swabs) to assess

whether they can be used to verify

exposure and to demonstrate a

biological effect (i.e., inflammatory

response) from exposure to red tide.

There are no costs to respondents. The

total burden is estimated to be 201

hours.

Respondents Number of

respondents

Number of

responses per

respondent

Average

burden per

response

(in hrs.)

Pulmonary History Questionnaire ................................................................................................ 100 1 20/60

Symptom Questionnaire .............................................................................................................. 100 20 5/60

Dated: September 19, 2000.

Nancy Cheal,

Acting Associate Director for Policy,

Planning, and Evaluation, Centers for Disease

Control and Prevention (CDC).

[FR Doc. 00–24530 Filed 9–22–00; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

Advisory Committee on Immunization

Practices: Meeting

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(P.L. 92–463), the Centers for Disease

Control and Prevention (CDC)

announces the following committee

meeting:

Name: Advisory Committee on

Immunization Practices (ACIP)

Teleconference.

Time and Date: 3:15 p.m.–5 p.m.,

September 28, 2000.

Place: Teleconference call will originate at

the Centers for Disease Control and

Prevention in Atlanta, Georgia. Please see

‘‘Supplementary Information’’ for details on

accessing the teleconference.

Status: Open to the public, teleconference

access limited only by availability of

telephone ports.

Purpose: The Committee is charged with

advising the Director, CDC, on the

appropriate uses of immunizing agents. In

addition, under 42 U.S.C. § 1396s, the

Committee is mandated to establish and

periodically review and, as appropriate,

revise the list of vaccines for administration

to vaccine-eligible children through the

Vaccines for Children (VFC) program, along

with schedules regarding the appropriate

periodicity, dosage, and contraindications

applicable to the vaccines.

Matters to be Discussed: The

teleconference agenda will include a

discussion of influenza vaccine

recommendations for the 2000–2001

influenza season. Discussion will include

priority groups for vaccination,

implementation measures, and strategies for

promoting vaccine delivery later in the

influenza season.

Agenda items are subject to change as

priorities dictate.

SUPPLEMENTARY INFORMATION: This

conference call is scheduled for 3:15

p.m. Eastern Standard Time. To access

the teleconference you must dial 1/888/

381–5770 and enter conference code

53651. You will then be automatically

connected to the call. It is necessary to

meet on an expedited basis, to refine

vaccine recommendations prior to the

influenza season. Therefore, notice is

published less than 15 days prior to the

teleconference.

CONTACT PERSON FOR MORE INFORMATION:

Gloria A. Kovach, Program Analyst,

Epidemiology and Surveillance

Division, National Immunization

Program, CDC, 1600 Clifton Road, NE,

m/s E61, Atlanta, Georgia 30333.

Telephone 404/639–8096. The Director,

Management Analysis and Services

office has been delegated the authority

to sign Federal Register notices

pertaining to announcements of

meetings and other committee

management activities for both the